A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

NCT00994175 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Severe, Refractory Asthma
Airway Inflammation
Airflow Obstruction

Interventions

DRUG: Pioglitazone
DRUG: Placebo

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)